Deutsche Bank Raises PT On St. Jude Medical To $60
Deutsche Bank has raised the price target on St. Jude Medical (NYSE: STJ) from $57 to $60 and maintains its Buy rating.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Deutsche Bank st. jude medicalPrice Target Analyst Ratings